Dose Response AMP Challenge Study With Beclometasone Dipropionate (BDP)/Formoterol Pressurised Metered Dose Inhaler (pMDI)

Clinical trial NCT01343745 · COMPLETED

Trial details

NCT number: NCT01343745
Sponsor: Chiesi Farmaceutici S.p.A.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Persistent Asthma

Start date: 2008-02-01
Primary completion: 2008-08-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.